Table 3.
Demographical and clinical parameters of the systemic lupus erythematosus (SLE) patients.
| SLE (n = 21) | |
|---|---|
| Age, (years), mean (range) | 48.35 (27.00–70.00) |
| Gender, (f/m) | 21/0 |
| Age at diagnosis, (years) | 33.00 (14.50) |
| Disease duration, (years), median (range) | 7.00 (2.00–24.00) |
| SLEDAI score | 4.00 (3.25) |
| Clinical manifestations, n(%) | |
| Malar rash | 12 (57.1) |
| Photosensitivity | 16 (76.2) |
| Discoid lesions | 6 (28.6) |
| Arthritis | 10 (47.6) |
| Oral ulcers | 10 (47.6) |
| Serositis | 4 (19.0) |
| Renal disorder | 3 (14.3) |
| Neurological disorder | 0 (0.0) |
| Cytopenia | 11 (52.4) |
| Autoantibodies, n(%) | |
| ANAs | 21 (100) |
| Anti-dsDNA titer, (U/ml), mean ± SD | 25.30 ± 33.89 |
| Anti-SSa | 11 (52.4) |
| Anti-SSb | 2 (9.5) |
| Anti-Sm | 2 (9.5) |
| Anti-RNP | 1 (4.8) |
| Treatments, n (%) | |
| None or NSAIDs | 3 (14.2) |
| Antimalarials | 18 (85.7) |
Variables are represented as median (interquartile range) or n(%), unless otherwise stated.